These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38298432)

  • 21. Identification and Validation of
    Liu W; Zhu F; Yan J; Liu Y; Chen C; Zhang K; Zhao X; Chen J
    Onco Targets Ther; 2020; 13():11165-11176. PubMed ID: 33173308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upregulation of Glutamic-Oxaloacetic Transaminase 1 Predicts Poor Prognosis in Acute Myeloid Leukemia.
    Cheng Z; Dai Y; Zeng T; Liu Y; Cui L; Qian T; Si C; Huang W; Pang Y; Ye X; Shi J; Fu L
    Front Oncol; 2020; 10():379. PubMed ID: 32266153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A validation study of potential prognostic DNA methylation biomarkers in patients with acute myeloid leukemia using a custom DNA methylation sequencing panel.
    Šestáková Š; Cerovská E; Šálek C; Kundrát D; Ježíšková I; Folta A; Mayer J; Ráčil Z; Cetkovský P; Remešová H
    Clin Epigenetics; 2022 Feb; 14(1):22. PubMed ID: 35148810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SPINK2 is a prognostic biomarker related to immune infiltration in acute myeloid leukemia.
    Chen X; Zhao L; Yu T; Zeng J; Chen M
    Am J Transl Res; 2022; 14(1):197-210. PubMed ID: 35173838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and Biological Implications of Mutational Spectrum in Acute Myeloid Leukemia of FAB Subtypes M0 and M1.
    Cheng Z; Dai Y; Pang Y; Jiao Y; Zhao H; Wu S; Zhang L; Zhang Y; Wang X; Wang L; Ma D; Qin T; Hu N; Zhang Y; Hu K; Zhang Q; Shi J; Fu L
    Cell Physiol Biochem; 2018; 47(5):1853-1861. PubMed ID: 29961066
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Wang L; Jiang C; Hu D
    Aging (Albany NY); 2023 Jul; 15(14):6757-6773. PubMed ID: 37506247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Up-regulation of DDIT4 predicts poor prognosis in acute myeloid leukaemia.
    Cheng Z; Dai Y; Pang Y; Jiao Y; Liu Y; Cui L; Quan L; Qian T; Zeng T; Si C; Huang W; Chen J; Pang Y; Ye X; Shi J; Fu L
    J Cell Mol Med; 2020 Jan; 24(1):1067-1075. PubMed ID: 31755224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel Prognostic Signature for Acute Myeloid Leukemia: Bioinformatics Analysis of Combined CNV-Driven and Ferroptosis-Related Genes.
    Han C; Zheng J; Li F; Guo W; Cai C
    Front Genet; 2022; 13():849437. PubMed ID: 35559049
    [No Abstract]   [Full Text] [Related]  

  • 29. Prognostic value of the FUT family in acute myeloid leukemia.
    Dai Y; Cheng Z; Pang Y; Jiao Y; Qian T; Quan L; Cui L; Liu Y; Si C; Chen J; Ye X; Chen J; Shi J; Wu D; Zhang X; Fu L
    Cancer Gene Ther; 2020 Feb; 27(1-2):70-80. PubMed ID: 31209266
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Bai H; Zhou M; Zeng M; Han L
    DNA Cell Biol; 2020 Apr; 39(4):700-708. PubMed ID: 32077754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of the key genes and microRNAs in adult acute myeloid leukemia with FLT3 mutation by bioinformatics analysis.
    Chen S; Chen Y; Zhu Z; Tan H; Lu J; Qin P; Xu L
    Int J Med Sci; 2020; 17(9):1269-1280. PubMed ID: 32547322
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical significance and potential mechanism of heat shock factor 1 in acute myeloid leukemia.
    Lyu C; Wang Q; Yin X; Li Z; Wang T; Wang Y; Cui S; Liu K; Wang Z; Gao C; Xu R
    Aging (Albany NY); 2022 Sep; 14(17):7026-7037. PubMed ID: 36069792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening diagnostic markers for acute myeloid leukemia based on bioinformatics analysis.
    Chen W; Liu D; Wang G; Pan Y; Wang S; Tang R
    Transl Cancer Res; 2022 Jun; 11(6):1722-1729. PubMed ID: 35836534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low expression of the metabolism-related gene SLC25A21 predicts unfavourable prognosis in patients with acute myeloid leukaemia.
    Wang W; Liang Q; Zhao J; Pan H; Gao Z; Fang L; Zhou Y; Shi J
    Front Genet; 2022; 13():970316. PubMed ID: 36246603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive analysis of ECHDC3 as a potential biomarker and therapeutic target for acute myeloid leukemia: Bioinformatic analysis and experimental verification.
    Zhao Y; Niu LT; Hu LJ; Lv M
    Front Oncol; 2022; 12():947492. PubMed ID: 36172164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High expression of
    Lian J; Zhuang H; Li F; Pei R; Chen D; Ye P; Li S; Wang T; Cao J; Yuan J; Yu Z; Lu Y
    Hematology; 2024 Dec; 29(1):2381171. PubMed ID: 39087796
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Han Q; Zhang Q; Song H; Bamme Y; Song C; Ge Z
    Front Oncol; 2020; 10():149. PubMed ID: 32175272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High Expression of DC-STAMP Gene Predicts Adverse Outcomes in AML.
    Liang Q; Zhang L; Wang W; Zhao J; Li Q; Pan H; Gao Z; Fang L; Shi J
    Front Genet; 2022; 13():876689. PubMed ID: 35571050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dihydropyrimidinase-like 2 can serve as a novel therapeutic target and prognostic biomarker in acute myeloid leukemia.
    Li F; Ling Q; Lian J; Chen Y; Hu C; Yang M; Zhang X; Li C; Mao S; Ye W; Li X; Lin X; Wei W; Huang X; Pan J; Qian Y; Wang J; Lu Y; Jin J
    Cancer Med; 2023 Apr; 12(7):8319-8330. PubMed ID: 36621846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comprehensive analysis of nucleotide excision repair characteristics defines a novel prognostic signature for acute myeloid leukemia.
    Bu XX; Cong J; Ling L; Lu BB; Wu CY; Jiang F; Wang ZM; Chen J
    Eur Rev Med Pharmacol Sci; 2023 Aug; 27(15):6917-6930. PubMed ID: 37606102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.